Join us as we discuss:

Prehospital Blood Product and Crystalloid Resuscitation in the Severely Injured Patient
A Secondary Analysis of the Prehospital Air Medical Plasma Trial

Guyette FX, Sperry JL, Peitzman AB, Billiar TR, Daley BJ, Miller RS, Harbrecht BG, Claridge JA, Putnam T, Duane TM, Phelan HA, Brown JB. Prehospital Blood Product and Crystalloid Resuscitation in the Severely Injured Patient: A Secondary Analysis of the Prehospital Air Medical Plasma Trial. Ann Surg. 2021 Feb 1;273(2):358-364. doi: 10.1097/SLA.0000000000003324. PMID: 30998533.

Out for Blood! Is it time for EMS to give blood products in hemorrhagic shock?

Hemorrhage is the leading cause of preventable death following injury.  Large volume crystalloid resuscitation, the traditional prehospital intervention, may cause harm. The benefits of prehospital packed red blood cells (PRBCs), plasma, or transfusion of both products compared to crystalloids is unknown. Join us as we discuss the latest research from the PAMPer trial aimed to determine whether prehospital blood products reduce 30-day mortality in patients at risk for hemorrhagic shock compared with crystalloid only resuscitation.

Please join members of the Prehospital Care Research Forum and others on Monday, March 8, 2021, in discussing this topic.

Invite your students!

Pass this invitation along to your class to get them interested in EMS research. Consider broadcasting the webinar over the projector in your classroom for multiple viewers.

Have a suggestion for a future article? Email Dave Page with the details.

Hungry for more prehospital research? Listen to the recordings of prior meetings on YouTube or download the podcast version on the Fisdap blog.

Register for the Webinar